Cholesterol 27-hydroxylase but not apolipoprotein apoe contributes to A 2A adenosine receptor stimulated reverse cholesterol transport

Inflammation

Volumn 35, Issue 1, 2012, Pages 49-57

  Bingham, Taiese Crystal ^a   Parathath, Saj ^a   Tian, Heather ^a   Reiss, Allison ^b   Chan, Edwin ^a   Fisher, Edward A ^a   Cronstein, Bruce N ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WINTHROP UNIVERSITY HOSPITAL   (United States)

Author keywords

Adenosine; Atherosclerosis; Inflammation; Macrophages

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); ABC TRANSPORTER A1; ADENOSINE A2 RECEPTOR; APOLIPOPROTEIN E; CHOLESTANETRIOL 26 MONOOXYGENASE; GAMMA INTERFERON; LENTIVIRUS VECTOR; MESSENGER RNA; SMALL INTERFERING RNA;

APOLIPOPROTEIN E GENE; ARTICLE; CHOLESTEROL 27 HYDROXYLASE GENE; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; FOAM CELL; GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; PHARMACOLOGICAL STIMULATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR OCCUPANCY; WILD TYPE;

ADENOSINE; ADENOSINE A2 RECEPTOR AGONISTS; APOLIPOPROTEINS E; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; CHOLESTEROL; CYTOCHROME P-450 CYP27A1; FOAM CELLS; HUMANS; MACROPHAGES; PHENETHYLAMINES; RECEPTOR, ADENOSINE A2A; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 84859430577     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-010-9288-y     Document Type: Article

References (17)

1. 2A adenosine receptor stimulation decreases foam cell formation by enhancing ABCA1-dependent cholesterol efflux. Journal of Leukocyte Biology 87(4): 683-690. doi:jlb.070951310.1189/jlb.0709513.
2. Reiss, A.B., D.W. Wan, K. Anwar, J.T. Merrill, P.A. Wirkowski, N. Shah, B.N. Cronstein, E.S. Chan, and S.E. Carsons. 2009. Enhanced CD36 scavenger receptor expression in THP-1 human monocytes in the presence of lupus plasma: Linking autoimmunity and atherosclerosis. Experimental Biology and Medicine (Maywood) 234(3): 354-360. doi:0806-BC-19410.3181/0806-BC-194.
3. 2A receptor occupancy stimulates expression of proteins involved in reverse cholesterol transport and inhibits foam cell formation in macrophages. Journal of Leukocyte Biology 76(3): 727-734.
4. Reiss, A.B., C.A. Patel, M.M. Rahman, E.S. Chan, K. Hasneen, M. C. Montesinos, J.D. Trachman, and B.N. Cronstein. 2004. Interferon-gamma impedes reverse cholesterol transport and promotes foam cell transformation in THP-1 human monocytes/macrophages. Medical Science Monitor 10(11): BR420-BR425. doi:6060.
5. Reiss, A.B., N.W. Awadallah, S. Malhotra, M.C. Montesinos, E.S. Chan, N.B. Javitt, and B.N. Cronstein. 2001. Immune complexes and IFN-gamma decrease cholesterol 27-hydroxylase in human arterial endothelium and macrophages. Journal of Lipid Research 42 (11): 1913-1922. (Pubitemid 33116723)
6. Brodsky, J.L., and E.A. Fisher. 2008. The many intersecting pathways underlying apolipoprotein B secretion and degradation. Trends in Endocrinology and Metabolism 19(7): 254-259. doi:S1043-2760(08)00102-110.1016/j.tem.2008.07. 002.
7. Westman, J., B. Kallin, I. Bjorkhem, J. Nilsson, and U. Diczfalusy. 1998. Sterol 27-hydroxylase- and apoAI/phospholipid-mediated efflux of cholesterol from cholesterol-laden macrophages: evidence for an inverse relation between the two mechanisms. Arteriosclerosis, Thrombosis, and Vascular Biology 18(4): 554-561. (Pubitemid 28177894)
8. Norlin, M., and K. Wikvall. 2007. Enzymes in the conversion of cholesterol into bile acids. Current Molecular Medicine 7(2): 199-218. (Pubitemid 46488191)
9. Davignon, J., J.S. Cohn, L. Mabile, and L. Bernier. 1999. Apolipoprotein E and atherosclerosis: Insight from animal to human studies. Clinica Chimica Acta 286(1-2): 115-143. (Pubitemid 29406104)
10. Greenow, K., N.J. Pearce, and D.P. Ramji. 2005. The key role of apolipoprotein E in atherosclerosis. Journal of Molecular Medicine 83(5): 329-342. doi:10.1007/s00109-004-0631-3. (Pubitemid 41201798)
11. Chao, W.T., S.H. Tsai, Y.C. Lin, W.W. Lin, and V.C. Yang. 2005. Cellular localization and interaction of ABCA1 and caveolin-1 in aortic endothelial cells after HDL incubation. Biochemical and Biophysical Research Communications 332(3): 743-749. (Pubitemid 40745176)
12. Hara, S., T. Shike, N. Takasu, and T. Mizui. 1997. Lysophosphatidylcholine promotes cholesterol efflux from mouse macrophage foam cells. Arteriosclerosis, Thrombosis, and Vascular Biology 17 (7): 1258-1266. (Pubitemid 27329848)
13. Reiss, A.B., S.E. Carsons, K. Anwar, S. Rao, S.D. Edelman, H. Zhang, P. Fernandez, B.N. Cronstein, and E.S. Chan. 2008. Atheroprotective effects of methotrexate on reverse cholesterol transport proteins and foam cell transformation in human THP-1 monocyte/macrophages. Arthritis and Rheumatism 58(12): 3675-3683.
14. Fu, X., J.G. Menke, Y. Chen, G. Zhou, K.L. MacNaul, S.D. Wright, C.P. Sparrow, and E.G. Lund. 2001. 27-Hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells. The Journal of Biological Chemistry 276(42): 38378-38387.
15. Heeren, J., U. Beisiegel, and T. Grewal. 2006. Apolipoprotein E recycling: Implications for dyslipidemia and atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 26(3): 442-448.
16. Hatters, D.M., C.A. Peters-Libeu, and K.H. Weisgraber. 2006. Apolipoprotein E structure: Insights into function. Trends in Biochemical Sciences 31(8): 445-454. (Pubitemid 44108662)
17. Tall, A.R. 2008. Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins. Journal of Internal Medicine 263(3): 256-273. doi:JIM189810.1111/ j.1365-2796.2007.